Clinical Trial Update: Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing changes in cerebral glucose metabolism after 12 weeks of escitalopram treatment in Panic Disorder; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Samsung Medical Center | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED